Hyperlipidemia, Familial Combined - 24 Studies Found
| Completed |
: Lipid Efficacy/Tolerability Study (0524A-020) :
: 2005-12-21 :
|
| Completed |
: A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED) :
|
| Completed |
: Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED) :
: 2004-09-23 :
|
| Withdrawn |
: Efficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Mixed Hyperlipidemia and Two or More Risk Factors :
: 2008-08-19 :
|
| Withdrawn |
: Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia : Dyslipidemia : 2009-11-09 :
|
| Completed |
: Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036) :
: 2004-09-23 :
|
| Completed |
: A Pilot Study to Evaluate the Lipid Effects of TRIA-662 :
: 2013-12-06 :
|
| Completed |
: A Study to Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination (MK-0524A-114)(COMPLETED) :
: 2009-11-10 :
|
| Completed |
: Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care :
|